JP2006519782A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006519782A5 JP2006519782A5 JP2006502481A JP2006502481A JP2006519782A5 JP 2006519782 A5 JP2006519782 A5 JP 2006519782A5 JP 2006502481 A JP2006502481 A JP 2006502481A JP 2006502481 A JP2006502481 A JP 2006502481A JP 2006519782 A5 JP2006519782 A5 JP 2006519782A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrrolidone
- pharmaceutical composition
- rbmp
- nmp
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims 6
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical group CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 229920002988 biodegradable polymer Polymers 0.000 claims 2
- 239000004621 biodegradable polymer Substances 0.000 claims 2
- ZFPGARUNNKGOBB-UHFFFAOYSA-N 1-Ethyl-2-pyrrolidinone Chemical compound CCN1CCCC1=O ZFPGARUNNKGOBB-UHFFFAOYSA-N 0.000 claims 1
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 claims 1
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 claims 1
- 229940112869 bone morphogenetic protein Drugs 0.000 claims 1
- 239000013256 coordination polymer Substances 0.000 claims 1
- PZYDAVFRVJXFHS-UHFFFAOYSA-N n-cyclohexyl-2-pyrrolidone Chemical compound O=C1CCCN1C1CCCCC1 PZYDAVFRVJXFHS-UHFFFAOYSA-N 0.000 claims 1
- 230000011164 ossification Effects 0.000 claims 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims 1
Images
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/354,856 US7074412B2 (en) | 2003-01-30 | 2003-01-30 | Pharmaceutical composition |
| PCT/IB2004/000577 WO2004067027A2 (en) | 2003-01-30 | 2004-01-29 | Osteogenic composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006519782A JP2006519782A (ja) | 2006-08-31 |
| JP2006519782A5 true JP2006519782A5 (enExample) | 2007-03-01 |
Family
ID=32770436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006502481A Pending JP2006519782A (ja) | 2003-01-30 | 2004-01-29 | 医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7074412B2 (enExample) |
| EP (1) | EP1589989A2 (enExample) |
| JP (1) | JP2006519782A (enExample) |
| KR (1) | KR20050105446A (enExample) |
| CN (1) | CN100490893C (enExample) |
| AU (1) | AU2004208569B2 (enExample) |
| BR (1) | BRPI0407178A (enExample) |
| CA (1) | CA2513712A1 (enExample) |
| WO (1) | WO2004067027A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
| US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
| US7700819B2 (en) | 2001-02-16 | 2010-04-20 | Kci Licensing, Inc. | Biocompatible wound dressing |
| US7763769B2 (en) | 2001-02-16 | 2010-07-27 | Kci Licensing, Inc. | Biocompatible wound dressing |
| US7189409B2 (en) * | 2004-03-09 | 2007-03-13 | Inion Ltd. | Bone grafting material, method and implant |
| US20060258578A1 (en) * | 2005-05-10 | 2006-11-16 | The University Of Zurich | Pharmaceutical composition |
| KR100865759B1 (ko) * | 2007-05-07 | 2008-10-29 | 울산대학교 산학협력단 | 사람의 골형성단백질-2를 암호화하는 유전자를 이용한 재조합된 사람의 골형성단백질-2의 제조방법 |
| KR100932945B1 (ko) * | 2009-01-16 | 2009-12-21 | 원광대학교산학협력단 | 골 분말과 피브린 글루로 이루어진 고형의 스캐폴드 |
| KR100932947B1 (ko) * | 2009-01-16 | 2009-12-21 | 원광대학교산학협력단 | 안지오제닌을 함유하는 뼈 재생용 조성물 |
| KR100932948B1 (ko) * | 2009-01-16 | 2009-12-21 | 원광대학교산학협력단 | Ｂｍｐ-2를 함유하는 골 분말과 피브린 글루로 이루어진 고형의 스캐폴드 |
| US20150335400A1 (en) * | 2009-06-17 | 2015-11-26 | The Trustees Of Columbia University In The City Of New York | Tooth scaffolds |
| JP2012530548A (ja) | 2009-06-17 | 2012-12-06 | ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク | 歯の足場 |
| WO2012101173A1 (en) * | 2011-01-26 | 2012-08-02 | Universität Zürich | N-methyl-2-pyrrolidone for prevention and treatment of bone loss |
| WO2017019832A1 (en) * | 2015-07-29 | 2017-02-02 | Medivation Technologies, Inc. | Methods and compositions using repair cells and cationic dyes |
| WO2017019833A1 (en) * | 2015-07-29 | 2017-02-02 | Medivation Technologies, Inc. | Compositions containing repair cells and cationic dyes |
| US12383246B2 (en) | 2020-10-12 | 2025-08-12 | Abbott Cardiovascular Systems, Inc. | Vessel closure device with improved safety and tract hemostasis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5324519A (en) | 1989-07-24 | 1994-06-28 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
| GB8927546D0 (en) | 1989-12-06 | 1990-02-07 | Ciba Geigy | Process for the production of biologically active tgf-beta |
| EP0560014A1 (en) | 1992-03-12 | 1993-09-15 | Atrix Laboratories, Inc. | Biodegradable film dressing and method for its formation |
| US6992066B2 (en) | 1998-10-16 | 2006-01-31 | Zimmer Orthobiologics, Inc. | Povidone-containing carriers for polypeptide growth factors |
| US6143314A (en) | 1998-10-28 | 2000-11-07 | Atrix Laboratories, Inc. | Controlled release liquid delivery compositions with low initial drug burst |
| AU3699900A (en) * | 1999-02-16 | 2000-09-04 | Sulzer Biologics, Inc. | Device and method for regeneration and repair of cartilage lesions |
| US20030105530A1 (en) | 2001-12-04 | 2003-06-05 | Inion Ltd. | Biodegradable implant and method for manufacturing one |
| US6926903B2 (en) * | 2001-12-04 | 2005-08-09 | Inion Ltd. | Resorbable polymer composition, implant and method of making implant |
-
2003
- 2003-01-30 US US10/354,856 patent/US7074412B2/en not_active Expired - Fee Related
-
2004
- 2004-01-29 JP JP2006502481A patent/JP2006519782A/ja active Pending
- 2004-01-29 AU AU2004208569A patent/AU2004208569B2/en not_active Ceased
- 2004-01-29 CN CNB200480005562XA patent/CN100490893C/zh not_active Expired - Fee Related
- 2004-01-29 WO PCT/IB2004/000577 patent/WO2004067027A2/en not_active Ceased
- 2004-01-29 CA CA002513712A patent/CA2513712A1/en not_active Abandoned
- 2004-01-29 EP EP04706251A patent/EP1589989A2/en not_active Withdrawn
- 2004-01-29 KR KR1020057014086A patent/KR20050105446A/ko not_active Withdrawn
- 2004-01-29 BR BR0407178-6A patent/BRPI0407178A/pt not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006519782A5 (enExample) | ||
| Lee et al. | Gel scaffolds of BMP‐2‐binding peptide amphiphile nanofibers for spinal arthrodesis | |
| WO2004032862A3 (en) | Cyclodextrin-based materials, compositions and uses related thereto | |
| JP2005538045A5 (enExample) | ||
| JP2009532087A5 (enExample) | ||
| WO2010051541A3 (en) | Compositions containing delta-9-thc-amino acid esters and process of preparation | |
| WO2006029411A3 (en) | Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof | |
| EP2316490A3 (en) | Methods and compositions for enhanced delivery of bioactive molecules | |
| WO2006060723A3 (en) | Methods for producing block copolymer/amphiphilic particles | |
| JP2006517944A5 (enExample) | ||
| EA200601905A1 (ru) | Микрокапсулы с замедленным высвобождением, основанные на сополимере лактида и гликолида, включающие полипептид и сахар | |
| WO2006044362A3 (en) | N-sulfonylpiperidine cannabinoid receptor 1 antagonists | |
| JP2005247999A5 (enExample) | ||
| JP2007514664A5 (enExample) | ||
| JP2013535505A5 (enExample) | ||
| JP2005510521A5 (enExample) | ||
| JP2007504132A5 (enExample) | ||
| ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
| JP2005525355A5 (enExample) | ||
| EA200901393A1 (ru) | Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат | |
| JP2008531742A5 (enExample) | ||
| WO2006070325A3 (en) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists | |
| JP2002544214A5 (enExample) | ||
| JP2008515832A5 (enExample) | ||
| WO2004067027A3 (en) | Osteogenic composition |